Literature DB >> 6279516

Cell-mediated immunity in human cytomegalovirus infection.

M Fiorilli, M C Sirianni, P Iannetti, A Panà, M Divizia, F Aiuti.   

Abstract

The direct leukocyte migration inhibition test, in response to cytomegalovirus stimulation, was used to study cell-mediated immunity in a group of children with cytomegalovirus infection. The test was impaired in children with chronic disease associated with cytomegaloviruria. In those cases with no viruria at the moment of the test, leukocyte migration inhibition was normal. Our data suggest that the acquired chronic cytomegalovirus infection may be sustained by a state of specific cellular desensitization, as already demonstrated for congenital infection.

Entities:  

Mesh:

Year:  1982        PMID: 6279516      PMCID: PMC351171          DOI: 10.1128/iai.35.3.1162-1164.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Specific cellular unreactivity during cytomegalovirus infection in man.

Authors:  M Fiorilli; A Panà; M C Sirianni; A Spaziani; F Aiuti
Journal:  Boll Ist Sieroter Milan       Date:  1978-09-30

2.  Congenital cytomegalovirus infection: a fifteen year perspective.

Authors:  J B Hanshaw
Journal:  J Infect Dis       Date:  1971-05       Impact factor: 5.226

3.  Prevalence and duration of postnatally acquired human cytomegalovirus infection.

Authors:  J G Starr; E Gold
Journal:  J Chronic Dis       Date:  1970-02

4.  Definition of perinatal mortality.

Authors: 
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

5.  Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis.

Authors:  W P Carney; R H Rubin; R A Hoffman; W P Hansen; K Healey; M S Hirsch
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

6.  Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus (CMV) induced in vitro lymphocyte reactivity and its relationship to the production of CMV antibodies.

Authors:  C H ten Napel; T H The
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

7.  Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers.

Authors:  R C Gehrz; S C Marker; S O Knorr; J M Kalis; H H Balfour
Journal:  Lancet       Date:  1977-10-22       Impact factor: 79.321

  7 in total
  4 in total

1.  In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.

Authors:  Elvis B Kidzeru; Anneke C Hesseling; Jo-Ann S Passmore; Landon Myer; Hoyam Gamieldien; Christophe Toukam Tchakoute; Clive M Gray; Donald L Sodora; Heather B Jaspan
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

2.  Cytomegalovirus (CMV): specific lymphokine production in congenital CMV infection.

Authors:  R C Gehrz; T E Leonard
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

3.  Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).

Authors:  M C Sirianni; P Rossi; B Scarpati; G Ragona; R Seminara; G Bonomo; F Aiuti
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

4.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.